Vartholomatos E - Search Results

1

Deglucohellebrin: A Potent Agent for Glioblastoma Treatment.

Vartholomatos E, Alexiou GA, Markopoulos GS, Lazari D, Tsiftsoglou O, Chousidis I, Leonardos I, Kyritsis AP. Vartholomatos E, et al. Anticancer Agents Med Chem. 2020;20(1):103-110. doi: 10.2174/1871520619666191121110848. Anticancer Agents Med Chem. 2020. PMID: 31755397

2

DNA content is associated with malignancy of intracranial neoplasms.

Alexiou GA, Vartholomatos E, Goussia A, Dova L, Karamoutsios A, Fotakopoulos G, Kyritsis AP, Voulgaris S. Alexiou GA, et al. Among authors: vartholomatos e. Clin Neurol Neurosurg. 2013 Sep;115(9):1784-7. doi: 10.1016/j.clineuro.2013.04.015. Epub 2013 May 15. Clin Neurol Neurosurg. 2013. PMID: 23683441

3

Prognostic value of neutrophil-to-lymphocyte ratio in patients with glioblastoma.

Alexiou GA, Vartholomatos E, Voulgaris S. Alexiou GA, et al. Among authors: vartholomatos e. J Neurooncol. 2013 Dec;115(3):521-2. doi: 10.1007/s11060-013-1240-1. Epub 2013 Sep 15. J Neurooncol. 2013. PMID: 24037498 No abstract available.

4

Combination treatment for glioblastoma cells with tumor necrosis factor-related apoptosis-inducing ligand and oncolytic adenovirus delta-24.

Tsamis KI, Alexiou GA, Vartholomatos E, Kyritsis AP. Tsamis KI, et al. Among authors: vartholomatos e. Cancer Invest. 2013 Nov;31(9):630-8. doi: 10.3109/07357907.2013.849724. Cancer Invest. 2013. PMID: 24164301

5

Comparison of (99m)tc-tetrofosmin and (99m)tc-sestamibi uptake in glioma cell lines: the role of p-glycoprotein expression.

Alexiou GA, Xourgia X, Vartholomatos E, Tsiouris S, Kalef-Ezra JA, Fotopoulos AD, Kyritsis AP. Alexiou GA, et al. Among authors: vartholomatos e. Int J Mol Imaging. 2014;2014:471032. doi: 10.1155/2014/471032. Epub 2014 Nov 10. Int J Mol Imaging. 2014. PMID: 25436147 Free PMC article.

6

Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells.

Alexiou GA, Tsamis KI, Vartholomatos E, Peponi E, Tzima E, Tasiou I, Lykoudis E, Tsekeris P, Kyritsis AP. Alexiou GA, et al. Among authors: vartholomatos e. J Neurooncol. 2015 Jun;123(2):217-24. doi: 10.1007/s11060-015-1799-9. Epub 2015 May 3. J Neurooncol. 2015. PMID: 25935110

7

Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells.

Alexiou GA, Gerogianni P, Vartholomatos E, Kyritsis AP. Alexiou GA, et al. Among authors: vartholomatos e. Cancer Invest. 2016 Nov 25;34(10):489-495. doi: 10.1080/07357907.2016.1233424. Epub 2016 Oct 21. Cancer Invest. 2016. PMID: 27768402

8

^99mTc-Tetrofosmin Uptake Correlates with the Sensitivity of Glioblastoma Cell Lines to Temozolomide.

Alexiou GA, Xourgia X, Gerogianni P, Vartholomatos E, Kalef-Ezra JA, Fotopoulos AD, Kyritsis AP. Alexiou GA, et al. Among authors: vartholomatos e. World J Nucl Med. 2017 Jan-Mar;16(1):45-50. doi: 10.4103/1450-1147.181155. World J Nucl Med. 2017. PMID: 28217019 Free PMC article.

9

N-(p-coumaroyl) serotonin inhibits glioblastoma cells growth through triggering S-phase arrest and apoptosis.

Lazari D, Alexiou GA, Markopoulos GS, Vartholomatos E, Hodaj E, Chousidis I, Leonardos I, Galani V, Kyritsis AP. Lazari D, et al. Among authors: vartholomatos e. J Neurooncol. 2017 May;132(3):373-381. doi: 10.1007/s11060-017-2382-3. Epub 2017 Apr 1. J Neurooncol. 2017. PMID: 28365838

10

Moschamine inhibits proliferation of glioblastoma cells via cell cycle arrest and apoptosis.

Alexiou GA, Lazari D, Markopoulos G, Vartholomatos E, Hodaj E, Galani V, Kyritsis AP. Alexiou GA, et al. Among authors: vartholomatos e. Tumour Biol. 2017 May;39(5):1010428317705744. doi: 10.1177/1010428317705744. Tumour Biol. 2017. PMID: 28475011 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page